Skip to main content
Log in

Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery

  • PHARMACODYNAMICS
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background: The effects of prostaglandin E1 on pulmonary hypertension were assessed after protamine injection at the end of cardiopulmonary bypass during cardiac surgery.

Methods: Ten patients scheduled for cardiac surgery presented with pulmonary hypertension (mean pulmonary artery pressure greater than 30 mmHg) after protamine injection and were treated by infusion of 0.02 μg · kg−1 · min−1 prostaglandin E1. Hemodynamic measurements were made on occasions after cardiopulmonary bypass. Prostaglandin E1 decreased pulmonary artery pressure, pulmonary vascular resistance, right ventricular stroke work index and pulmonary vascular resistance/systemic vascular resistance ratio, but did not change blood pressure, systemic vascular resistance, left ventricular stroke work index or cardiac output.

Conclusion: Prostaglandin E1 normalized pulmonary hypertension after protamine injection, but did not change arterial blood pressure and cardiac output.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 22 August 1997 / Accepted in revised form: 30 October 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abe, K., Sakakibara, T., Miyamoto, Y. et al. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery. E J Clin Pharmacol 54, 21–25 (1998). https://doi.org/10.1007/s002280050414

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050414

Navigation